Table 1.
Clinical features of the studied patients with non-small cell lung carcinoma (NSCLC).
| Number | Age | Gender | Pathological stage |
|---|---|---|---|
| Case #1 | 60 | Male | I |
| Case #5 | 48 | Male | I |
| Case #12 | 69 | Male | I |
| Case #19 | 55 | Male | I |
| Case #26 | 59 | Female | I |
| Case #2 | 68 | Male | II |
| Case #4 | 60 | Male | II |
| Case #6 | 54 | Male | II |
| Case #11 | 66 | Male | II |
| Case #18 | 69 | Male | II |
| Case #20 | 69 | Female | II |
| Case #21 | 69 | Male | II |
| Case #22 | 64 | Male | II |
| Case #27 | 66 | Female | II |
| Case #3 | 50 | Male | III |
| Case #7 | 59 | Male | III |
| Case #8 | 49 | Female | III |
| Case #9 | 58 | Male | III |
| Case #10 | 76 | Male | III |
| Case #13 | 73 | Male | III |
| Case #14 | 46 | Male | III |
| Case #15 | 78 | Female | III |
| Case #16 | 79 | Female | III |
| Case #17 | 83 | Male | III |
| Case #23 | 66 | Female | III |
| Case #24 | 40 | Male | III |
| Case #25 | 45 | Male | III |
| Summary | Average: 62.14 ± 11.23 | Male (74.07%) | I (18.52%) II (29.63%) III (51.85%) |